Steward Partners Investment Advisory’s Definium Therapeutics DFTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$250K	Buy	13,240 +12,240	+1,224%	+$208K	﹤0.01%	1904
2025 Q4	$13.4K	Hold	1,000	–	–	﹤0.01%	3316
2025 Q3	$11.8K	Hold	1,000	–	–	﹤0.01%	3329
2025 Q2	$6.49K	Hold	1,000	–	–	﹤0.01%	3388
2025 Q1	$5.85K	Buy	1,000 +100	+11%	+$716	﹤0.01%	3331
2024 Q4	$6.26K	Buy	900 +400	+80%	+$2.75K	﹤0.01%	3287
2024 Q3	$2.85K	Buy	+500	New	+$3.48K	﹤0.01%	3364
2024 Q2	–	Sell	-6	Closed	-$56	–	3674
2024 Q1	$56	Hold	6	–	–	﹤0.01%	3520
2023 Q4	$22	Buy	+6	New	+$18	﹤0.01%	3476
2022 Q1	–	Sell	-180	Closed	-$4K	–	3336
2021 Q4	$4K	Hold	180	–	–	﹤0.01%	2893
2021 Q3	$6K	Hold	180	–	–	﹤0.01%	2757
2021 Q2	$9K	Buy	+180	New	+$9.45K	﹤0.01%	6257

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Steward Partners Investment Advisory's DFTX Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Definium Therapeutics (DFTX) stake by 1,224% in Q1 2026, buying an estimated $208K and bringing the position to 13,240 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Steward Partners Investment Advisory first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Steward Partners Investment Advisory held 13,240 shares of Definium Therapeutics worth $250K as of Q1 2026.
Steward Partners Investment Advisory bought 12,240 Definium Therapeutics shares in Q1 2026, an estimated $208K.
Definium Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1904 holding.
Steward Partners Investment Advisory first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.